ES2185652T3 - Oligopeptidos derivados de fragmentos de proteinas c-reactiva. - Google Patents

Oligopeptidos derivados de fragmentos de proteinas c-reactiva.

Info

Publication number
ES2185652T3
ES2185652T3 ES94916966T ES94916966T ES2185652T3 ES 2185652 T3 ES2185652 T3 ES 2185652T3 ES 94916966 T ES94916966 T ES 94916966T ES 94916966 T ES94916966 T ES 94916966T ES 2185652 T3 ES2185652 T3 ES 2185652T3
Authority
ES
Spain
Prior art keywords
fragments
oligopeptides derived
reactive proteins
oligopeptides
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94916966T
Other languages
English (en)
Inventor
Patrizia Caretto
Flavio Leoni
Fabrizio Marcucci
Gianni Gromo
Paolo Mascagni
Massimo Pinori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Italfarmaco SpA
Original Assignee
Italfarmaco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco SpA filed Critical Italfarmaco SpA
Application granted granted Critical
Publication of ES2185652T3 publication Critical patent/ES2185652T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4737—C-reactive protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A OLIGOPEPTIDOS DERIVADOS DE FRAGMENTOS DE LA PROTEINA C REACTIVA (A PARTIR DE AHORA DENOMINADA CRP) Y A SU USO COMO AGENTES INMUNOMODULADORES, Y PARA EL TRATAMIENTO DE ENFERMEDADES CARDIOVASCULARES E INFLAMATORIAS.
ES94916966T 1993-10-12 1994-05-16 Oligopeptidos derivados de fragmentos de proteinas c-reactiva. Expired - Lifetime ES2185652T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI932154A IT1271486B (it) 1993-10-12 1993-10-12 Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva

Publications (1)

Publication Number Publication Date
ES2185652T3 true ES2185652T3 (es) 2003-05-01

Family

ID=11367010

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94916966T Expired - Lifetime ES2185652T3 (es) 1993-10-12 1994-05-16 Oligopeptidos derivados de fragmentos de proteinas c-reactiva.

Country Status (19)

Country Link
US (1) US6057295A (es)
EP (1) EP0723552B1 (es)
JP (1) JP3221881B2 (es)
KR (1) KR100363408B1 (es)
CN (1) CN1041524C (es)
AT (1) ATE226591T1 (es)
AU (1) AU684511B2 (es)
CA (1) CA2173939C (es)
DE (1) DE69431603T2 (es)
DK (1) DK0723552T3 (es)
ES (1) ES2185652T3 (es)
FI (1) FI961584A (es)
HU (1) HUT75538A (es)
IL (1) IL109761A0 (es)
IT (1) IT1271486B (es)
NO (1) NO961423L (es)
PT (1) PT723552E (es)
WO (1) WO1995010531A1 (es)
ZA (1) ZA943610B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342481B1 (en) * 1993-10-12 2002-01-29 Italfarmaco S.P.A. Oligopeptides derived from C-reactive protein fragments
EP1408031A1 (en) * 2002-10-09 2004-04-14 3 D Gene Pharma Pyrolidine derivatives useful in treatment of hepatitis C virus infection
EP2350118B1 (en) 2008-09-19 2016-03-30 Nektar Therapeutics Carbohydrate-based drug delivery polymers and conjugates thereof
CN102947341B (zh) 2010-01-19 2018-07-06 哈佛大学校长及研究员协会 用于病原体检测和治疗的工程化调理素
CA2842321C (en) 2011-07-18 2022-05-03 President And Fellows Of Harvard College Engineered microbe-targeting molecules and uses thereof
EP2976642A4 (en) 2013-03-15 2016-09-21 Harvard College METHODS AND COMPOSITIONS FOR IMPROVING THE DETECTION AND / OR CAPTURE OF A TARGET ENTITY
EP3010522B1 (en) 2013-05-21 2021-01-20 President and Fellows of Harvard College Engineered heme-binding compositions and uses thereof
US10513546B2 (en) 2013-12-18 2019-12-24 President And Fellows Of Harvard College CRP capture/detection of gram positive bacteria
US10435457B2 (en) 2015-08-06 2019-10-08 President And Fellows Of Harvard College Microbe-binding molecules and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945239A1 (de) * 1979-11-09 1981-05-21 Troponwerke GmbH & Co KG, 5000 Köln Oligopeptide, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4353823A (en) * 1981-09-01 1982-10-12 Chipens Gunar I Synthetic analog of tuftisin
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
DE3783280T2 (de) * 1986-07-16 1993-05-06 Eniricerche Spa Teilweise retro-invertierte analoge des tuftsin, methode zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
IT1254883B (it) * 1992-04-16 1995-10-11 Italfarmaco Spa Tetrapeptidi parzialmente modificati e retroinvertiti, analoghi di frammenti della proteina c-reattiva.

Also Published As

Publication number Publication date
IL109761A0 (en) 1994-08-26
FI961584A0 (fi) 1996-04-11
DK0723552T3 (da) 2003-02-24
ITMI932154A1 (it) 1995-04-12
JP3221881B2 (ja) 2001-10-22
FI961584A (fi) 1996-04-11
US6057295A (en) 2000-05-02
EP0723552A1 (en) 1996-07-31
CN1041524C (zh) 1999-01-06
AU684511B2 (en) 1997-12-18
HU9600934D0 (en) 1996-08-28
DE69431603T2 (de) 2003-03-13
CA2173939A1 (en) 1995-04-20
DE69431603D1 (de) 2002-11-28
NO961423D0 (no) 1996-04-11
ITMI932154A0 (it) 1993-10-12
CN1133048A (zh) 1996-10-09
WO1995010531A1 (en) 1995-04-20
IT1271486B (it) 1997-05-28
CA2173939C (en) 2002-08-27
KR100363408B1 (ko) 2003-02-11
EP0723552B1 (en) 2002-10-23
JPH09503200A (ja) 1997-03-31
PT723552E (pt) 2003-02-28
NO961423L (no) 1996-06-10
ZA943610B (en) 1995-01-25
HUT75538A (en) 1997-05-28
AU6844194A (en) 1995-05-04
ATE226591T1 (de) 2002-11-15

Similar Documents

Publication Publication Date Title
EA200400241A1 (ru) Направленные к мишени мультимерные контрастные вещества, основанные на пептидах
CL2011000010A1 (es) Anticuerpo monoclonal anti-peptido beta-amiloide; polinucleotido que lo codifica; hibridoma; metodo de produccion; composicion que lo comprende; uso para tratar enfermedades relacionadas con proteinas amiloides; metodo de diagnostico de las mismas; y kit que lo comprende.
AR038568A1 (es) Anticuerpos anti-a beta y su uso
ATE172743T1 (de) Nachweis von kollagenabbau -i(in vivo)
BR0013231A (pt) Complexos citocina-anticorpo múltiplos
DE60327205D1 (de) Therapeutische antiköper mit reduzierten nebenwirkungen
DK2316852T3 (da) Stabiliserede enkeltdomæne-antistoffer
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
BR0009206A (pt) Isolamento e análise de proteina
DE69638269D1 (de) Hochaffine humane antikörper gegen tumorantigene
EA199700265A1 (ru) Добавочный протеин рецептора интерлейкина-1 человека
PE20061444A1 (es) Anticuerpo anti-mcp-1, composiciones, metodos y usos
PT1084146E (pt) Proteina hibrida para inibicao de desgranulacao de mastocitos e seu uso
EA200801174A1 (ru) Антитела-миметики glp-2, полипептиды, композиции, способы и применения
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
BR0312521A (pt) Métodos para a separação e a purificação de fibrinogênio e de pelo menos uma outra proteìna e para a co-purificação de fibrinogênio e de fator xiii, uso de cromatografia de afinidade com ìon de metal imobilizado, fibrinogênio, kit farmacêutico, e, formulações farmacêutica e de fibrinogênio liofilizado
IS8308A (is) Amínósýrur með sækni fyrir a2o prótíninu
BRPI0514672A (pt) polipeptìdeos de fusobacterium e métodos de uso
ES2185652T3 (es) Oligopeptidos derivados de fragmentos de proteinas c-reactiva.
DK1145012T3 (da) Fremgangsmåder og kits til sekventering af polypeptider
PT840620E (pt) Antagonistas de il-8 para o tratamento de asma
EA200600042A1 (ru) Способы образования дисульфидных связей и гликозилирования белков и реагенты, применяемые в этих способах
ECSP034743A (es) Peptidos a partir del anticuerpo 16/61d para tratar lupus eritematoso sistemico
DK1387854T3 (da) SFRP og peptidmotiver som interagerer med SFRP og fremgangsmåder til anvendelse deraf
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение